340B Update: HRSA Finalizes 340B Pricing & Penalties for Drug Manufacturers
By EsqSocial Corporation 19/01/17
On January 5, 2017, the U.S. Department of Health and Human Services (“HHS”) and the Health Resources and Services Administration (“HRSA”) issued a final rule on the calculation of drug ceiling prices under the 340B Drug Pricing Program (the “340B...
By: K&L Gates LLP